Valuation: Lonza Group AG

Market Cap 40.17B 49.7B 43.44B 36.87B 69.77B 4,789B 70.98B 479B 188B 2,339B 187B 183B 8,074B P/E 2026 *
34.7x
P/E 2027 * 28.5x
Enterprise Value 43.39B 53.68B 46.92B 39.82B 75.36B 5,172B 76.66B 517B 203B 2,526B 202B 197B 8,720B EV / Sales 2026 *
6.08x
EV / Sales 2027 * 5.39x
Free-Float
99.36%
Yield 2026 *
0.95%
Yield 2027 * 1.08%
1 day+0.10%
1 week-1.77%
Current month+5.46%
1 month+16.68%
3 months+5.93%
6 months+5.42%
Current year+7.03%
1 week 568.6
Extreme 568.6
588.8
1 month 484
Extreme 484
591
Current year 454.6
Extreme 454.6
591
1 year 454.6
Extreme 454.6
594.8
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2024
Director of Finance/CFO 54 01/12/2021
Chief Operating Officer - 01/10/2025
Director TitleAgeSince
Director/Board Member 67 26/04/2016
Director/Board Member 66 04/05/2018
Director/Board Member 60 05/05/2022
Date Insider Type Main position Quantity % Market Cap.
5/8/26 A Buy 460 0.0007%
5/8/26 A Buy 618 0.0009%
3/11/26 A Buy 60 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.10%-1.77%+0.98%+6.36% 49.7B
-2.85%-6.25%+366.61%+572.09% 38.09B
+1.98%+4.82%+13.71%+61.68% 35.29B
+1.78%+0.73%+32.68%-4.80% 35.13B
+0.06%+1.56%+4.41%+27.42% 27.22B
-3.27%-5.67% - - 16.14B
+1.64%+0.45%+70.86%+121.18% 15.36B
+1.01%+1.80%+15.77%+19.51% 13.89B
-1.21%+0.73%+18.02%-30.96% 13.02B
-1.01%-3.91%+1,259.03%+642.77% 11.76B
Average -0.18%-0.78%+198.01%+157.25% 25.56B
Weighted average by Cap. -0.04%-0.74%+134.13%+142.62%

Financials

2026 *2027 *
Net sales 7.14B 8.83B 7.72B 6.55B 12.4B 851B 12.61B 85.13B 33.44B 416B 33.16B 32.43B 1,434B 7.99B 9.89B 8.64B 7.33B 13.88B 953B 14.12B 95.3B 37.44B 465B 37.12B 36.31B 1,606B
Net income 1.16B 1.44B 1.25B 1.06B 2.01B 138B 2.05B 13.84B 5.44B 67.53B 5.39B 5.27B 233B 1.4B 1.73B 1.52B 1.29B 2.43B 167B 2.48B 16.72B 6.57B 81.59B 6.51B 6.37B 282B
Net Debt 3.21B 3.98B 3.48B 2.95B 5.58B 383B 5.68B 38.34B 15.06B 187B 14.94B 14.61B 646B 2.92B 3.61B 3.15B 2.68B 5.07B 348B 5.15B 34.78B 13.66B 170B 13.55B 13.25B 586B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,000
Date Price Change Volume
17/07/26 CHF 574.00 -0.21% 28,004
16/07/26 CHF 575.20 -1.07% 154,646
15/07/26 CHF 581.40 -0.17% 142,597
14/07/26 CHF 582.40 -1.05% 100,085
13/07/26 CHF 588.60 +0.44% 142,361
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
575.20CHF
Average target price
669.22CHF
Spread / Average Target
+16.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock